Nexalin Technology Stock Analysis
NXL Stock | USD 3.82 0.08 2.05% |
Nexalin Technology is overvalued with Real Value of 2.95 and Target Price of 3.0. The main objective of Nexalin Technology stock analysis is to determine its intrinsic value, which is an estimate of what Nexalin Technology is worth, separate from its market price. There are two main types of Nexalin Technology's stock analysis: fundamental analysis and technical analysis.
The Nexalin Technology stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Nexalin |
Nexalin Stock Analysis Notes
About 23.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.65. Nexalin Technology had not issued any dividends in recent years. Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company was incorporated in 2021 and is headquartered in Houston, Texas. Nexalin Technology operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 3 people. To find out more about Nexalin Technology contact Mark White at (832) 260-0222 or learn more at https://www.nexalin.com.Nexalin Technology Quarterly Total Revenue |
|
Nexalin Technology Investment Alerts
Nexalin Technology is way too risky over 90 days horizon | |
Nexalin Technology appears to be risky and price may revert if volatility continues | |
Nexalin Technology has 4.46 K in debt. Nexalin Technology has a current ratio of 0.2, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for Nexalin to invest in growth at high rates of return. | |
The entity reported the last year's revenue of 110.75 K. Reported Net Loss for the year was (4.65 M) with profit before taxes, overhead, and interest of 958.14 K. | |
Nexalin Technology has about 291.33 K in cash with (3.84 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.06. | |
Nexalin Technology has a frail financial position based on the latest SEC disclosures | |
Roughly 23.0% of the company outstanding shares are owned by corporate insiders | |
Latest headline from fool.com.au: Top broker says ASX 300 tech stock has 18 percent upside after sell-off |
Nexalin Technology Upcoming and Recent Events
25th of March 2024 Upcoming Quarterly Report | View | |
31st of December 2023 Next Fiscal Quarter End | View |
Nexalin Largest EPS Surprises
Earnings surprises can significantly impact Nexalin Technology's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2024-09-30 | 2024-09-30 | -0.12 | -0.23 | -0.11 | 91 |
Nexalin Technology Environmental, Social, and Governance (ESG) Scores
Nexalin Technology's ESG score is a quantitative measure that evaluates Nexalin Technology's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Nexalin Technology's operations that may have significant financial implications and affect Nexalin Technology's stock price as well as guide investors towards more socially responsible investments.
Nexalin Technology Thematic Classifications
In addition to having Nexalin Technology stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Medical EquipmentUSA Equities from Medical Equipment industry as classified by Fama & French |
Nexalin Market Capitalization
The company currently falls under 'Micro-Cap' category with a total capitalization of 50.16 M.Nexalin Profitablity
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (1.32) | (1.38) | |
Return On Capital Employed | (1.78) | (1.69) | |
Return On Assets | (1.28) | (1.34) | |
Return On Equity | (1.45) | (1.38) |
Management Efficiency
Nexalin Technology has Return on Asset of (1.1892) % which means that on every $100 spent on assets, it lost $1.1892. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (2.0223) %, meaning that it generated no profit with money invested by stockholders. Nexalin Technology's management efficiency ratios could be used to measure how well Nexalin Technology manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -1.38. Return On Capital Employed is expected to rise to -1.69 this year. At this time, Nexalin Technology's Net Tangible Assets are quite stable compared to the past year. Non Current Assets Total is expected to rise to about 212.1 K this year, although the value of Total Current Assets will most likely fall to about 2.6 M.Last Reported | Projected for Next Year | ||
Book Value Per Share | 0.44 | 0.46 | |
Tangible Book Value Per Share | 0.42 | 0.44 | |
Enterprise Value Over EBITDA | (0.42) | (0.44) | |
Price Book Value Ratio | 0.93 | 0.98 | |
Enterprise Value Multiple | (0.42) | (0.44) | |
Price Fair Value | 0.93 | 0.98 | |
Enterprise Value | 2.4 M | 2.3 M |
The management strategies employed by Nexalin Technology's are designed to enhance shareholder value and ensure long-term growth. We assess the effectiveness of these strategies in our stock analysis.
Operating Margin (48.32) | Beta 3.567 | Return On Assets (1.19) | Return On Equity (2.02) |
Technical Drivers
As of the 22nd of November, Nexalin Technology secures the Mean Deviation of 8.33, risk adjusted performance of 0.1818, and Downside Deviation of 7.95. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Nexalin Technology, as well as the relationship between them. Please verify Nexalin Technology coefficient of variation, as well as the relationship between the treynor ratio and semi variance to decide if Nexalin Technology is priced some-what accurately, providing market reflects its recent price of 3.82 per share. Given that Nexalin Technology has jensen alpha of 2.6, we recommend you to check Nexalin Technology's last-minute market performance to make sure the company can sustain itself at a future point.Nexalin Technology Price Movement Analysis
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Nexalin Technology middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Nexalin Technology. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Nexalin Technology Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Nexalin Technology insiders, such as employees or executives, is commonly permitted as long as it does not rely on Nexalin Technology's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Nexalin Technology insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Nexalin Technology Predictive Daily Indicators
Nexalin Technology intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Nexalin Technology stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Accumulation Distribution | 84995.59 | |||
Daily Balance Of Power | (0.20) | |||
Rate Of Daily Change | 0.98 | |||
Day Median Price | 3.7 | |||
Day Typical Price | 3.74 | |||
Price Action Indicator | 0.08 | |||
Period Momentum Indicator | (0.08) |
Nexalin Technology Corporate Filings
10Q | 8th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8K | 1st of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 30th of October 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 2nd of October 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 25th of September 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 19th of September 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 3rd of September 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 15th of August 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Nexalin Technology Forecast Models
Nexalin Technology's time-series forecasting models are one of many Nexalin Technology's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Nexalin Technology's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Nexalin Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Nexalin Technology prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Nexalin shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Nexalin Technology. By using and applying Nexalin Stock analysis, traders can create a robust methodology for identifying Nexalin entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (41.98) | (44.07) | |
Operating Profit Margin | (51.43) | (48.86) | |
Net Loss | (41.98) | (44.07) | |
Gross Profit Margin | 0.77 | 0.50 |
Current Nexalin Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Nexalin analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Nexalin analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
3.0 | Buy | 1 | Odds |
Most Nexalin analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Nexalin stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Nexalin Technology, talking to its executives and customers, or listening to Nexalin conference calls.
Nexalin Stock Analysis Indicators
Nexalin Technology stock analysis indicators help investors evaluate how Nexalin Technology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Nexalin Technology shares will generate the highest return on investment. By understating and applying Nexalin Technology stock analysis, traders can identify Nexalin Technology position entry and exit signals to maximize returns.
Begin Period Cash Flow | 162.7 K | |
Common Stock Shares Outstanding | 7.4 M | |
Total Stockholder Equity | 3.2 M | |
Property Plant And Equipment Net | 496.00 | |
Cash And Short Term Investments | 2.9 M | |
Cash | 580.2 K | |
Accounts Payable | 159.5 K | |
Net Debt | -575.8 K | |
50 Day M A | 1.7736 | |
Total Current Liabilities | 425.3 K | |
Other Operating Expenses | 5.8 M | |
Non Current Assets Total | 202 K | |
Non Currrent Assets Other | 96.5 K | |
Stock Based Compensation | 2.4 M |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nexalin Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. For more information on how to buy Nexalin Stock please use our How to buy in Nexalin Stock guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexalin Technology. If investors know Nexalin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nexalin Technology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.65) | Revenue Per Share 0.02 | Quarterly Revenue Growth (0.24) | Return On Assets (1.19) | Return On Equity (2.02) |
The market value of Nexalin Technology is measured differently than its book value, which is the value of Nexalin that is recorded on the company's balance sheet. Investors also form their own opinion of Nexalin Technology's value that differs from its market value or its book value, called intrinsic value, which is Nexalin Technology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nexalin Technology's market value can be influenced by many factors that don't directly affect Nexalin Technology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nexalin Technology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nexalin Technology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nexalin Technology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.